BOT 2.67% 38.5¢ botanix pharmaceuticals ltd

Management speak of optionality BOT definitely not short of that...

  1. 408 Posts.
    lightbulb Created with Sketch. 107
    Management speak of optionality BOT definitely not short of that in house we have two leading candidates BTX 1503 (moderate to severe acne) and BTX1801 (Antimicrobial). 1503 the bigger market but 1801 faster to market. Also possible other applications of SB (hands, feet etc)

    "Botanix intends to leverage a range of existing US Food and Drug Administration (FDA) programs (e.g.Qualified Infection Disease Product, Fast Track and Limited Population Pathway for Antimicrobial andAntifungal Drugs status) to accelerate BTX 1801 clinical development, reduce clinical costs and increasethe exclusivity period."

    Looking forward to management guidance on what the next product will be.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
38.5¢
Change
0.010(2.67%)
Mkt cap ! $687.8M
Open High Low Value Volume
37.5¢ 39.0¢ 37.0¢ $1.040M 2.722M

Buyers (Bids)

No. Vol. Price($)
6 89969 38.0¢
 

Sellers (Offers)

Price($) Vol. No.
38.5¢ 207639 9
View Market Depth
Last trade - 14.19pm 26/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.